Psychedelics as Novel Therapeutics in Alzheimer's Disease: Rationale and Potential Mechanisms.
Current Topics in Behavioral Neurosciences 2022 Albert Garcia‐romeu, Sean Darcy, Hillary Jackson et al.
Serotonin 2A receptor (5-HT2AR) agonist "classic psychedelics" are drawing increasing interest as potential mental health treatments. Recent work suggests psychedelics can exert persisting anxiolytic and antidepressant effects lasting up to several months after a single administration. Data indicate acute subjective drug effects as important psychological factors involved in observed...